Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)

被引：1
|
作者：
Wong, Hui-li
Karasinska, Joanna M.
Jones, Martin
Eirew, Peter
Schrader, Kasmintan
Lim, Howard
Shen, Yaoqing
Jones, Steven
Yip, Stephen
Laskin, Janessa
Marra, Marco
Schaeffer, David F.
Renouf, Daniel J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.PANCA16-B81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B81
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
    Babiker, Hani M.
    Karass, Michael
    Recio-Boiles, Alejandro
    Chandana, Sreenivasa R.
    McBride, Ali
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 583 - 592
  • [32] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Biomarkers for subtypes of pancreatic ductal adenocarcinoma
    Venkatesan, Priya
    LANCET ONCOLOGY, 2017, 18 (12): : E718 - E718
  • [34] Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC)
    Radulovic, Petra
    Kruslin, Bozo
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 18 (03) : 246 - 251
  • [35] Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
    Michalak, Natalia
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [36] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [37] pH Regulatory Transporters in Pancreatic Ductal Adenocarcinoma (PDAC)
    Kong, Su Chii
    Christensen, Sandra
    Hoffmann, Else Kay
    Novak, Ivana
    Pedersen, Stine Falsig
    FASEB JOURNAL, 2013, 27
  • [38] Efficacy of olaparib therapy in metastatic pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD).
    Tan, Elaine
    Hicks, James Kevin
    Blue, Kirsten
    Kim, Richard D.
    Carballido, Estrella M.
    Kim, Dae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Safety and efficacy of chemotherapy in older adults with locally advanced and metastatic pancreatic ductal adenocarcinoma (PDAC)
    Ostios-Garcia, Lorena
    Saade, Patricia
    Grossman, Joseph Elan
    Lanniello, Leanne
    Bullock, Andrea J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [40] Skeletal metastases in advanced pancreatic ductal adenocarcinoma (PDAC): A retrospective analysis.
    Puri, Akshjot
    Chang, John
    Dragovich, Tomislav
    Lucente, Patricia
    Kundranda, Madappa N.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345